(2r,3s,4s,5r,6r)-5-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-6-(2-phenylethoxy)oxane-3,4-diol

(2R,3S,4S,5R,6R)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-6-(2-phenylethoxy)oxane-3,4-diol

UWKRNCNWJVCHGZ-DERWZFJFSA-N CHEBI:183997 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: UWKRNCNWJVCHGZ-DERWZFJFSA-N
InChI Key: UWKRNCNWJVCHGZ-DERWZFJFSA-N
IUPAC name: (2R,3S,4S,5R,6R)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-6-(2-phenylethoxy)oxane-3,4-diol
Preferred name: (2r,3s,4s,5r,6r)-5-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-6-(2-phenylethoxy)oxane-3,4-diol
INN name: —
Synonym: —
ChEBI: CHEBI:183997

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

4-Octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING

Observed in differential profiles

Control_vs_DMXAA16h